IQVIA reports medicine spending rose in 2022 due to COVID vaccines, therapies
Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.